Lubna Choudhury

Also affiliated with Brigham and Women's Hospital, Temple College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial”.

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01505-4

N/A

3.8DataRank · unranked

134 citations

Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more

Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR

JACC. Clinical electrophysiology(2021)10.1016/j.jacep.2021.04.004

N/A

0.578DataRank · unranked

46 citations

John Dimarco, Paul Kolm, Carolyn Y. Ho, Milind Y. Desai, Raymond Y. Kwong +30 more

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010314

N/A

0.104DataRank · unranked

1 citations

Mitra Mastali, Jennifer E. Van Eyk, E. John Orav, Christoffer Rasmus Vissing, Sharlene M. Day +27 more

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

Nature Genetics(2025)10.1038/s41588-025-02087-4

N/A

0DataRank · unranked

55 citations

Sean L. Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Dominique M West +95 more

Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.09.016

N/A

0DataRank · unranked

1 citations

Mark V. Sherrid, Lubna Choudhury, Pablo García‐Pavía, Christopher M. Kramer, Roberto Barriales‐Villa +18 more

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

Nature Genetics(2021)10.1038/s41588-020-00764-0

N/A

0DataRank · unranked

344 citations

Anuj Goel, Christopher Grace, Kate Thomson, Steffen E. Petersen, Xiao Hua Xu +64 more

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

medRxiv(2025)10.1101/2025.09.15.25335783

N/A

0DataRank · unranked

0 citations

Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Matteo Castrichini +47 more

Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR

Journal of Cardiovascular Magnetic Resonance(2021)10.1186/s12968-021-00828-y

N/A

0DataRank · unranked

13 citations

Ryan Avery, Gilles Soulat, Bradley D. Allen, Jeremy D. Collins, Lubna Choudhury +5 more

Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias

Journal of the American Heart Association(2024)10.1161/jaha.123.030467

N/A

0DataRank · unranked

12 citations

Lisa Dellefave‐Castillo, Garima Tomar, Lisa D. Wilsbacher, Lubna Choudhury, David Y. Barefield +11 more